This study was designed to analyse possible associations between DNA polymorphisms in the 5-hydroxytryptamine (5-HT ; serotonin) 5-HT 2A receptor and the 5-HT transporter (5-HTT) genes, and myocardial infarction (MI). 5-HT has been shown to be involved in cardiovascular pathophysiology. In addition to platelet aggregation and vascular contraction, 5-HT induces hyperplasia of artery smooth muscle cells. Recently, a 5-HT transporter gene polymorphism has been associated with MI. To determine the influence of genetic variation at the 5-HT 2A receptor (T102C polymorphism) and the 5-HTT (insertion/deletion polymorphism) on the risk of developing early MI, we genotyped 210 MI patients of 55 years old and 238 healthy control subjects for DNA polymorphisms in these genes. In addition, we genotyped 95 patients with lateonset MI ( 60 years old) to analyse the effects of these polymorphisms on the age at which the first MI episode occurred. The 5-HT 2A receptor polymorphism was not associated with MI in our population. In addition, since the 5-HT 2A receptor gene and genotype frequencies did not differ between patients with early and late onset of MI, this polymorphism does not appear to have an effect on age at the first MI episode. Gene and genotype frequencies for the 5-HTT promoter did not differ between patients 55 years old and healthy controls (independent of smoking status). However, homozygotes for the deletion (the ss genotype, where s denotes the short allele) were present at a significantly higher frequency in patients 60 years old compared with patients 55 years old (P l 0.009 ; P l 0.004 when only smokers were compared). According to our data, the ss genotype would seem to have a protective role against MI, delaying the age of onset of the first episode, especially among smokers. This could be a consequence of the lower 5-HTT levels linked to the s allele, so that individuals homozygous for the ss genotype may have lower 5-HT re-uptake by platelets.
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with the clinical response to 5-HT #A receptor antagonists, suggesting that this polymorphism influences 5-HT #A receptor function [6] .
5-HT is transported by the 5-HT transporter (5-HTT), which is encoded by a polymorphic gene. One of the 5-HTT polymorphisms is located in the promoter region, approx. 1 kb upstream of the transcription initiation site. This polymorphism is a 44 bp insertion\ deletion, and the insertion (long ; l) allele has been associated with higher promoter activity and increased 5-HT uptake in blood platelets [7] .
Some of the effects of 5-HT, such as vascular contraction and platelet aggregation, can lead to thrombus formation, and have been implicated in the pathogenesis of myocardial infarction (MI) [8] . Moreover, smoking is a well-documented risk factor for cardiovascular disease, and an increased 5-HT receptor density among smokers has been described [5] . Thus polymorphisms in the 5-HT #A receptor and 5-HTT genes could influence the risk of developing MI [9] [10] [11] . To investigate the relationship between polymorphisms in the 5-HT #A receptor (T102C) and 5-HTT [(l\s (long\short)] genes and MI, we genotyped a number of MI patients and compared them with healthy control subjects.
METHODS

Subjects
A total of 305 consecutive male patients (210 younger than 55 years old, and 95 aged 60 years or older) were analysed. These patients attended the Cardiology Unit between January 1996 and December 1999, and were diagnosed with having a first episode of MI, defined according to WHO criteria. A total of 238 control subjects were also analysed. These controls (blood donors and Hospital staff) were male and healthy. Patients and controls were Caucasians from the same region (Asturias, Northern Spain ; total population 1 million). The study was approved by the Ethical Committee of Asturias Hospital Central, and informed consent was obtained from each participant.
5-HT 2A receptor and 5-HTT genotyping
Genomic DNA was obtained from each patient and control subject. For the analysis of the 5-HTT polymorphism, genomic DNA was PCR-amplified in a final volume of 30 µl containing 30 pmol of each primer (forward, 5h-GGCGTTGCCGCTCTGAATTGC-3h ; reverse, 5h-GAGGGACTGAGCTGGACAACCCAC3h), 2 mM of each dNTP, 2 mM MgCl # , 1iTaq polymerase buffer and 1 unit of Taq DNA polymerase. After 35 cycles of 95 mC for 30 s, 65 mC (annealing) for 1 min and 72 mC for 2 min, 15 µl of the reaction mixture was electrophoresed on a 3 % (w\v) agarose gel. Alleles were visualized, after ethidium bromide staining, as fragments of 484 bp (s allele) and 528 bp (l allele).
For analysis of the T102C polymorphism of the 5-HT #A receptor gene, a 342 bp fragment was PCRamplified with primers 5h-TCTGCTACAAGTTCTG-GCTT-3h (forward) and 5h-CTGCAGCTTTTTCTCT-AGGG-3h (reverse). PCR conditions were as described for the 5-HTT sequence, with an annealing temperature of 62 mC. Each reaction was digested with the restriction enzyme MspI, and electrophoresed on a 3 % (w\v) agarose gel. Alleles were visualized as fragments of 342 bp (102T) and 216j126 bp (102C).
Statistical analysis
The Chi-square test was used to compare genotype and gene frequencies between the groups. The odds ratios (ORs) and their 95 % confidence interval (95 % CI) were also calculated. ANOVA was used to compare average values of biochemical parameters between genotypes. The effect of genotype on the age of first MI episode was analysed by logistic regression. All statistical analyses were performed using the SPSS computer program. Table 1 summarizes the characteristics of the patients and control subjects. All patients had at least one risk factor for coronary artery disease (they were smokers and\or had hypertension and\or had hypercholesterolaemia). Early MI was strongly associated with smoking (patients 55 years old compared with controls : P 0.0001 ; OR l 23, 95 % CI 12.44-44.70). Average values of biochemical parameters did not differ between patients and controls, although patients 55 years old had higher cholesterol and triacylglycerol (triglyceride) and lower high-density lipoprotein-cholesterol values compared with controls. Table 2 summarizes the frequencies of 5-HTT (insertion\deletion at the promoter region) and 5-HT #A receptor (T102C) polymorphisms in patients and controls. The 5-HT #A receptor allele and genotype frequencies did not differ between patients 55 years old and controls, or between the two groups of patients. This suggests that this polymorphism neither contributes to the risk of developing MI nor influences the age of the first MI episode.
RESULTS
Gene and genotype frequencies for the 5-HTT polymorphism did not differ between patients 55 years old and controls. When we only compared smokers, patients 55 years old had a higher frequency of the ll genotype [36 % in patients (n l 201) compared with 25 % in controls (n l 99)], but the difference remained nonsignificant (P l 0.088).
The ll genotype was present at a significantly higher frequency in MI patients 55 years old compared with patients 60 years old (P l 0.009 ; OR l 2.13, 95 % CI 1.18-3.78), suggesting an effect of this polymorphism on the age of the first MI episode. The difference was even greater when only smokers were compared [36 % (n l 201) for patients 55 years old compared with 17 % for patients 60 years old (n l 81) ; P l 0.004]. Patients with the ll genotype had a significantly lower age at first MI than patients with the ls or ss genotype (48.29p12.08 and 54.92p13.96 years respectively ; P 0.001). This difference was also found when only the patients 55 years old were compared (ll genotype, 43p6 years ; ls or ss genotype, 45p5 years ; P l 0.017).
Biochemical values did not differ according to 5-HT #A receptor or 5-HTT genotype in patients 55 years old, controls or patients 60 years old. In addition, no differences were found when only patients with hypertension were compared (results not shown).
DISCUSSION
Platelet aggregation contributes to thrombus formation, which leads to episodes of MI [1] . As an inductor of platelet aggregation and vascular contraction, 5-HT has been implicated in coronary artery disease. This is also supported by the observation that inhibitors of 5-HT reuptake protect against MI [8] . In addition, 5-HT stimulates the hyperplasia of artery smooth muscle, thus contributing to the endothelial dysfunction that characterizes the pathogenesis of cardiovascular disease [2] .
In the present study, we genotyped a number of MI patients and healthy control subjects for DNA polymorphisms in the genes encoding the 5-HT #A receptor and 5-HTT. Our aim was to elucidate whether the variation at these genes contributes to the risk of suffering a MI, or has any effect on the age at the first MI episode. The two polymorphisms have been linked to several neuropsychiatric diseases, a fact that suggests a functional effect of these gene variants on protein levels or 5-HT binding affinities [12] [13] [14] [15] [16] [17] [18] [19] [20] . Moreover, the 5-HTT variant is located in the promoter sequence, and the deletion (s) allele reduced gene transcription in a reporter gene construct [21, 22] . This would explain the association between the l variant and more rapid 5-HT uptake in platelets [7] .
According to our data, the 5-HT #A receptor (T102C) polymorphism was not associated with the risk of developing MI in our population. In addition, gene and genotype frequencies for this polymorphism did not differ between patients with an early ( 55 years old) or late ( 60 years old) first MI episode, suggesting a lack of association with the age of onset of MI.
An association between the 5-HTT ll genotype and MI has been described among Japanese subjects [9] . More recently, Fumeron et al. [23] reported an increased frequency of this genotype in a case-control study based on 671 male MI patients from four European populations. In our population, the ll genotype was present at a non-significantly higher frequency among MI patients 55 years old compared with total controls, and the difference was greater when only smokers were compared. However, this genotype was at a significantly lower frequency among MI patients 60 years old compared with those 55 years old, and the difference was again greater when only smokers were compared. Moreover, patients with the ll genotype were significantly younger than patients with the ls or ss genotype. According to our data, the ss genotype appears to have a protective effect, delaying the onset of the first MI episode, and this effect is more relevant among smokers. It is possible that the association between the 5-HTT polymorphism and MI depends on accumulated cigarette consumption. In this case, smokers with the ll genotype would have their first MI episode at a lower accumulated cigarette consumption, showing a lower average age compared with smokers with the ls or ss genotype.
Our work has several limitations, some of which are inherent to most case-control studies. First, we analysed a limited number of patients and control subjects. However, we genotyped individuals from a homogeneous population, and the frequencies of the two polymorphisms were in Hardy-Weinberg equilibrium, suggesting that the observed frequencies represent the true gene and genotype frequencies in our population. In addition, the association between a gene variant and MI could depend on the cardiovascular risk factors in each population. Cigarette smoking is strongly associated with MI in our population, and smokers are likely to have an increased platelet 5-HT #A receptor density [5] . It is thus possible that polymorphisms in 5-HT-related genes contribute to the risk of MI in populations where smoking is the commonest risk factor, but not in populations where hypercholesterolaemia or hypertension play a more important role as risk factors for MI.
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